Rethinking primary prevention of atherosclerosis-related diseases.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-12-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.570358PMID 17146003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• Maternal Immunization Programs Postnatal Immune Responses and Reduces Atherosclerosis in Offspring

  2006cited by this paper
• Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

  2006cited by this paper
• Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

  2006cited by this paper
• Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis

  2006cited by this paper
• Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.

  2005cited by this paper
• Prone Spontaneously Hypertensive Rats

  2005cited by this paper
• Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis.

  2005cited by this paper
• Early Carotid Atherosclerosis in Overweight Non-diabetic Individuals is Associated with Subclinical Chronic Inflammation Independent of Underlying Insulin Resistance

  2005cited by this paper
• Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.

  2005cited by this paper
• PPAR‐gamma modulates allergic inflammation through up‐regulation of PTEN

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?

  2005cited by this paper
• Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.

  2005cited by this paper
• Childhood obesity, inflammation, and apnea: what is the future for our children?

  2005cited by this paper
• Endothelial Dysfunction in Childhood Infection

  2005cited by this paper
• New trends in anti-atherosclerotic agents.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

  2005cited by this paper
• Azithromycin for the secondary prevention of coronary events.

  2005cited by this paper
• Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer The Women ’ s Health Study : A Randomized Controlled Trial

  2005cited by this paper
• Beneficial effects of PPAR-γ ligands in ischemia–reperfusion injury, inflammation and shock

  2005cited by this paper
• Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction.

  2005cited by this paper
• Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

  2004cited by this paper
• New Risk Factors for Atherosclerosis and Patient Risk Assessment

  2004cited by this paper
• Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

  2004cited by this paper
• Beta Blocker and Angiotensin-Converting Enzyme Inhibitor Therapy Is Associated with Decreased Th1/Th2 Cytokine Ratios and Inflammatory Cytokine Production in Patients with Chronic Heart Failure

  2004cited by this paper
• Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.

  2004cited by this paper
• Carotid atherosclerosis and cardiovascular risk factors: a comparison of residents of a rural area of Okinawa with residents of a typical suburban area of Fukuoka, Japan.

  2004cited by this paper
• Effects of Diet and Exercise on Obesity-Related Vascular Dysfunction in Children

  2004cited by this paper
• Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile.

  2004cited by this paper
• Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

  2004cited by this paper
• Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis.

  2004cited by this paper
• Low‐grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia

  2004cited by this paper
• Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial Function

  2003cited by this paper
• Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study.

  2003cited by this paper
• Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score

  2003cited by this paper
• Endothelial Dysfunction: A Marker of Atherosclerotic Risk

  2003cited by this paper
• American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science.

  2003cited by this paper
• Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis.

  2003cited by this paper
• Renin-angiotensin system and atherothrombotic disease: from genes to treatment.

  2003cited by this paper
• Oxidation of LDL, Atherogenesis, and Apoptosis

  2003cited by this paper
• Microarray analysis: a novel research tool for cardiovascular scientists and physicians

  2003cited by this paper
• Statin effects beyond lipid lowering--are they clinically relevant?

  2003cited by this paper
• Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events

  2003cited by this paper
• Estrogen plus progestin and the risk of coronary heart disease.

  2003cited by this paper
• Prevalence of conventional risk factors in patients with coronary heart disease.

  2003cited by this paper
• New insights in the transcriptional activity and coregulator molecules in the arterial wall.

  2002cited by this paper
• Effect of Treatment for Chlamydia pneumoniae and Helicobacter pylori on Markers of Inflammation and Cardiac Events in Patients With Acute Coronary Syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA)

  2002cited by this paper
• The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol‐lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis

  2002cited by this paper
• Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells.

  2002cited by this paper
• Maternal Hypercholesterolemia During Pregnancy Promotes Early Atherogenesis in LDL Receptor-Deficient Mice and Alters Aortic Gene Expression Determined by Microarray

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime

  2002cited by this paper
• AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

  2002cited by this paper
• AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

  2001cited by this paper
• New Recommendations from the 1999 American College of Cardiology/American Heart Association Acute Myocardial Infarction Guidelines

  2001cited by this paper
• Maternal hypercholesterolemia during pregnancy influences the later devolopment of atherosclerosis: clinical and pathogenic implications

  2001cited by this paper
• PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

  2001cited by this paper
• Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

  2001cited by this paper
• AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

  2001cited by this paper
• Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.

  2001cited by this paper
• Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study

  2001cited by this paper
• Nitric oxide and atherosclerosis.

  2001cited by this paper
• Maternal Energy Stores and Diet Composition During Pregnancy Program Adolescent Blood Pressure

  2001cited by this paper
• Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

  2001cited by this paper
• Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril

  2001cited by this paper
• Age-Related Effects on Atherogenesis and Scavenger Enzymes of Intracranial and Extracranial Arteries in Men Without Classic Risk Factors for Atherosclerosis

  2001cited by this paper
• Maternal Hypercholesterolemia and Treatment During Pregnancy Influence the Long-Term Progression of Atherosclerosis in Offspring of Rabbits

  2001cited by this paper
• Multiple role of reactive oxygen species in the arterial wall

  2001cited by this paper
• Primäre Prävention kardiovaskulärer Ereignisse durch ASS und Vitamin E PPP das “Primary Prevention Project”

  2001cited by this paper
• Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction.

  2001cited by this paper
• c-myc activation in early coronary lesions in experimental hypercholesterolemia.

  2001cited by this paper
• Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications.

  2001cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• Primary prevention of coronary heart disease in women through diet and lifestyle.

  2000cited by this paper
• Primary prevention of coronary heart disease in women through diet and lifestyle.

  2000cited by this paper
• Evidence for Oxidative Activation of c-Myc–Dependent Nuclear Signaling in Human Coronary Smooth Muscle Cells and in Early Lesions of Watanabe Heritable Hyperlipidemic Rabbits: Protective Effects of Vitamin E

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells

  2000cited by this paper
• Maternal Hypercholesterolemia Enhances Atherogenesis in Normocholesterolemic Rabbits, Which Is Inhibited by Antioxidant or Lipid-Lowering Intervention During Pregnancy: An Experimental Model of Atherogenic Mechanisms in Human Fetuses

  2000cited by this paper
• Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

  2000cited by this paper
• Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

  2000cited by this paper
• Vitamin E and heart disease: basic science to clinical intervention trials.

  2000cited by this paper
• Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

  2000cited by this paper
• PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

  2000cited by this paper
• Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study.

  1999cited by this paper
• 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.

  1999cited by this paper
• Primordial prevention of cardiovascular disease through applied genetics.

  1999cited by this paper
• Ordeals for the fetal programming hypothesis

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Is normal pregnancy atherogenic?

  1999cited by this paper
• Neonatal intima formation in the human coronary artery.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper

• Multimodal Retinal Imaging Evaluation of Macular Degeneration Persistent Disease Activity Animal Model in Watanabe Heritable Hyperlipidemic Rabbits.

  2025cites this paper
• Exploring global research trends in Chinese medicine for atherosclerosis: a bibliometric study 2012–2023

  2024cites this paper
• Transgenerational Epigenetic Inheritance of Cardiovascular Diseases: A Network Medicine Perspective

  2024cites this paper
• Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases.

  2023cites this paper
• Mediator complex in neurological disease

  2023cites this paper
• Basic Pathogenic Mechanisms and Epigenetic Players Promoted by Extracellular Vesicles in Vascular Damage

  2023cites this paper
• Simulation of Ultrasound RF Signals Backscattered from a 3D Model of Pulsating Artery Surrounded by Tissue

  2022cites this paper
• Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review

  2021cites this paper
• Novel Insights Regarding Nitric Oxide and Cardiovascular Diseases

  2021cites this paper
• Causative Mechanisms of Childhood and Adolescent Obesity Leading to Adult Cardiometabolic Disease: A Literature Review

  2021cites this paper
• Emerging Anti-Atherosclerotic Therapies

  2021cites this paper
• DNA Methylation Profile of the SREBF2 Gene in Human Fetal Aortas

  2021cites this paper
• ABCA1, TCF7, NFATC1, PRKCZ, and PDGFA DNA methylation as potential epigenetic-sensitive targets in acute coronary syndrome via network analysis

  2021cites this paper
• Inflammation and enhanced atherogenesis in the carotid artery with altered blood flow in an atherosclerosis‐resistant mouse strain

  2021cites this paper
• Soft drinks and sweeteners intake: Possible contribution to the development of metabolic syndrome and cardiovascular diseases. Beneficial or detrimental action of alternative sweeteners?

  2021cites this paper
• MANUFACTURING AND POSITIONING (GENERATIONS) OF OIL‐IN‐WATER NANOSIZED EMULSIONS

  2020cites this paper
• Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases.

  2020cites this paper
• Network Medicine Approach in Prevention and Personalized Treatment of Dyslipidemias.

  2020cites this paper
• DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study

  2020cites this paper
• Early targeted DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in different stages of impaired glucose homeostasis Cardiovascular Diabetology

  2020cites this paper
• Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease

  2019cites this paper
• Resveratrol attenuates oxidative injury in human umbilical vein endothelial cells through regulating mitochondrial fusion via TyrRS-PARP1 pathway

  2019cites this paper
• Increasing evidence of pathogenic role of the Mediator (MED) complex in the development of cardiovascular diseases.

  2019cites this paper
• The Protective Activities of Dietary Sea Cucumber Cerebrosides against Atherosclerosis through Regulating Inflammation and Cholesterol Metabolism in Male Mice

  2018cites this paper
• Role of endogenous H2S in the attenuation of nickel-induced cell toxicity

  2018cites this paper
• Sodium Tanshinone II A Sulfonate for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials

  2018influential citation
• Associations between Job Strain and Arterial Stiffness: A Large Survey among Enterprise Employees from Thailand

  2018cites this paper
• From lipid locus to drug target through human genomics.

  2018cites this paper
• Prevention of Atherosclerosis by Berries: The Case of Blueberries.

  2018cites this paper
• Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in Humans

  2018cites this paper
• The influence of maternal body mass index and physical activity on select cardiovascular risk factors of preadolescent Hispanic children

  2018cites this paper
• Partitioning the heritability of coronary artery disease highlights the importance of immune-mediated processes and epigenetic sites associated with transcriptional activity

  2017influential citation
• An integrated approach to coronary heart disease diagnosis and clinical management.

  2017cites this paper
• Assessment of Social, Dietary and Biochemical Correlates of Cardiometabolic Risk in Pre-adolescent Hispanic Children

  2017influential citation
• Pattern Analysis of the Kinematics in Ultrasound Videos of the Common Carotid Artery – Application to Cardiovascular Risk Evaluation

  2017cites this paper
• Hexim1 heterozygosity stabilizes atherosclerotic plaque and decreased steatosis in ApoE null mice fed atherogenic diet.

  2017cites this paper
• Multifunctional nanosized emulsions for theragnosis of life threatening diseases

  2017cites this paper
• Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes

  2016cites this paper
• Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target.

  2016cites this paper
• Fusion of fibrous cap thickness and wall shear stress to assess plaque vulnerability in coronary arteries: a pilot study

  2016cites this paper
• Novel epigenetic-based therapies useful in cardiovascular medicine.

  2016cites this paper
• Bioavailability of Citrus Flavanones and Their Effect on Cardiovascular Health Biomarkers

  2015cites this paper
• Real-time ultrasound-tagging to track the 2D motion of the common carotid artery wall in vivo.

  2015cites this paper
• The use of therapeutic apheresis in cardiovascular disease

  2014cites this paper
• Effect of 7-Difluoromethyl-5, 4′-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE−/− mice induced by a cholesterol-rich diet

  2013cites this paper
• The function of dietary phenolic acids in cardiovascular health

  2013cites this paper
• MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans.

  2013cites this paper
• Contemporary Reviews in Cardiovascular Medicine Primary Prevention of Atherosclerosis A Clinical Challenge for the Reversal of Epigenetic Mechanisms

  2012cites this paper
• The Role of Statin Therapy for Primary Prevention: What is the Evidence?

  2012cites this paper
• Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.

  2012cites this paper
• “Cerebrovascular stressing”: dipyridamole-induced S100B elevation predicts ischemic cerebrovascular events

  2012cites this paper
• Estimation du mouvement bi-dimensionnel de la paroi artérielle en imagerie ultrasonore par une approche conjointe de segmentation et de speckle tracking

  2012cites this paper
• Subclinical Coronary Atherosclerosis Predicts Cardiovascular Risk in Different Stages of Hypertension: Result of the Heinz Nixdorf Recall Study

  2012cites this paper
• MicroRNA-145 Targeted Therapy Reduces Atherosclerosis

  2012cites this paper
• The novel role of epigenetics in primary prevention of cardiovascular diseases

  2012cites this paper
• Von Willebrand Factor, and Soluble Intercellular and Vascular Cell Adhesion Molecules as Indices of Endothelial Activation in Patients with Congenital Hypothyroidism

  2011cites this paper
• Fetoplacental Vascular Endothelial Dysfunction as an Early Phenomenon in the Programming of Human Adult Diseases in Subjects Born from Gestational Diabetes Mellitus or Obesity in Pregnancy

  2011cites this paper
• Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients

  2011influential citation
• Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.

  2011cites this paper
• Developmental Mechanisms Involved in the Primary Prevention of Atherosclerosis and Cardiovascular Disease

  2011cites this paper
• Importance of glycemic control.

  2011cites this paper
• Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage.

  2011cites this paper
• Atherosclerotic Plaque Regression and Arterial Reverse Remodelling in Carotid and Femoral Arteries by Statin Use in Primary Prevention Setting: Ultrasound Findings

  2011cites this paper
• Assessment of Endothelial Function in Clinical Practice

  2011cites this paper
• Is there a Benefit to Screening for Abdominal Aortic Aneurysm in the Irish Male Population between the ages of 55 to 75 years; an Ideal Opportunity Group for Evaluating Cardiovascular Risk Factors?

  2011cites this paper
• Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease

  2011cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Right coronary artery flow velocity and volume assessment with spiral K‐space sampled breathhold velocity‐encoded MRI at 3 tesla: Accuracy and reproducibility

  2010cites this paper
• Matching pathophysiology and evidence-based medicine for optimal management of ischemic heart disease

  2010cites this paper
• The effect of the long term aspirin administration on the progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse.

  2010cites this paper
• Plasma circulatory markers in male and female patients with coronary artery disease.

  2010cites this paper
• Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals.

  2010cites this paper
• The Impact of Lifestyle and Cardiovascular Risk Factors in Midlife on the Health-Related Quality of Life among Old Men

  2010cites this paper
• Protective Effects of Food on Cardiovascular Diseases

  2010cites this paper
• Age-Associated Decrease of High-Density Lipoprotein-Mediated Reverse Cholesterol Transport Activity

  2009cites this paper
• Hiperlipidemias y ateroesclerosis. Diagnóstico y tratamiento

  2009cites this paper
• "…it appears to be important not only to foster translational research, but also to enable the concurrent development and implementation of the necessary educational tools."

  2009cites this paper
• Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease

  2009cites this paper
• Systems biology and personalized prevention.

  2009cites this paper
• Novel pathogenic insights in the primary prevention of cardiovascular disease.

  2009cites this paper
• Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; no positive results for treatment

  2009cites this paper
• Incident coronary artery calcium among postmenopausal women.

  2008cites this paper
• Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis

  2008cites this paper
• Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.

  2008cites this paper
• Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia

  2008cites this paper
• p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice.

  2008cites this paper
• Nutrition, lipids, and cardiovascular disease: Clinical benefits without biochemical effects and biochemical effects without clinical benefits

  2008cites this paper
• Prevalence of unrecognized dyslipidaemia in Dubai and Northern Emirates: a cross-sectional hospital based study.

  2008cites this paper
• New approaches to the concept of primary prevention of atherosclerosis

  2008cites this paper
• Down-regulation of bile acid synthesis and a metabolic co-activator under hypoxic conditions - implications in obstructive sleep apnea.

  2008cites this paper
• Are We Getting Nearer to Screening for Atherosclerosis?

  2008cites this paper
• Proteomics and cardiovascular disease: an update.

  2008cites this paper
• Nutrition and cardiovascular disease: putting a pathogenic framework into focus.

  2007cites this paper
• Microcirculation and oxidative stress

  2007cites this paper
• Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells.

  2007cites this paper
• Frontiers in nephrology: early atherosclerosis--a view beyond the lumen.

  2007cites this paper
• Pharmacotherapeutic decisions in menopausal women with cardiovascular risk

  2007cites this paper
• Treating hypercholesterolemia and hypertension based on lifetime global risk.

  2007cites this paper
• EFFECT OF L-ARGININE SUPPLEMENTATION ON THE CONCENTRATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A CHOLESTEROL-RICH DIET WITHDRAWAL MODEL

  2007cites this paper
• Digital Commons @ East Tennessee State University Digital Commons @ East Tennessee State University

  year unknowncites this paper